Related references
Note: Only part of the references are listed.Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis
Guanfang Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)
Direct interaction between CD155 and CD96 promotes immunosuppression in lung adenocarcinoma
Hui Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
4-1BB costimulation promotes bystander activation of human CD8 T cells
Manuel Reithofer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
Taofei Zeng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
Joe-Marc Chauvin et al.
CLINICAL CANCER RESEARCH (2020)
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation
Tram N. Dao et al.
CANCERS (2020)
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer
Ralph Ja Maas et al.
ONCOIMMUNOLOGY (2020)
CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15-and IL-21-Driven NK Cell Proliferation
Laurent Vidard et al.
JOURNAL OF IMMUNOLOGY (2019)
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo et al.
CANCERS (2019)
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Aimee Merino et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
Norimichi Hattori et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
Inaki Etxeberria et al.
ESMO OPEN (2019)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity
Amelia Roman Aguilera et al.
ONCOIMMUNOLOGY (2018)
TIGIT Expression Positively Associates with NK Cell Function in AML Patients
Bei Jia et al.
BLOOD (2018)
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
Cariad Chester et al.
BLOOD (2018)
NK cell education via nonclassical MHC and non-MHC ligands
Yuke He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Contribution of inhibitory receptor TIGIT to NK cell education
Yuke He et al.
JOURNAL OF AUTOIMMUNITY (2017)
TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
Nicholas A. Manieri et al.
TRENDS IN IMMUNOLOGY (2017)
Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions
Feng Xu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
Dhifaf Sarhan et al.
CANCER RESEARCH (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals
Feng Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Natural Killer Cell Functional Activity After 4-1BB Costimulation
Shadi Sadat Navabi et al.
INFLAMMATION (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells
S. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR
Noa Stanietsky et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of 4-1BB:4-1BB ligand in cancer immunotherapy
ATC Cheuk et al.
CANCER GENE THERAPY (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Share Paper
